The industry continues to gradually move away from RFLPs (i.e, 1-4-4, 1-8-4, 1-7-4), which are unreliable indicators of genetic relationships, and has instead classified PRRS into groups known as ...
Implementation of universal germline testing in underserved patients with young onset gastrointestinal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Accurate interpretation of cancer genomics depends on standardized disease classification, tumor characterization and variant annotation. In this joint COSMIC and QIAGEN webinar, we show how these ...
SAN FRANCISCO, March 12, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant Modeling, a ...
Doctors across multiple countries are flagging a painful new COVID-19 symptom tied to a fast-spreading variant: a sore throat ...
While the delta COVID-19 variant is the dominant strain in the U.S., it’s now officially the dominant strain worldwide “by far,” officials from the World Health Organization said during a Sept. 21 ...